News | AHA | July 24, 2025

Eight Companies Selected to Drive Tech Improvements for AHA Heart and Brain Accelerator

Eight companies have been named to the second cohort of the American Heart Association Heart and Brain Health Accelerator.

Eight Companies Selected to Drive Tech Improvements for AHA Heart and Brain Accelerator

July 22, 2025 — In a collaboration between American Heart Association Ventures and the Association’s Center for Health Technology and Innovation, eight companies have been selected to participate in the American Heart Association Heart and Brain Health Accelerator.

Through the Accelerator, the American Heart Association, a global force changing the future of health for all, aims to drive innovation with the potential to enhance patient outcomes, lower costs and reduce barriers to care. This is one of many ways the Association is exploring cutting-edge technology solutions that are scalable, accessible and effective, ensuring that everyone, everywhere can live longer, healthier lives.

“Innovation is essential to advancing health and improving outcomes for people affected by heart disease and stroke,” said Lisa Suennen, managing partner of American Heart Association Ventures. “Through the Heart and Brain Health Accelerator, we’re proud to support breakthrough technologies with the potential to transform care. By connecting these companies to mentorship, funding and our network of experts, we aim to accelerate their path from promising concept to lifesaving impact.”

The Heart Association’s Heart and Brain Health Accelerator is one track within the larger MedTech Innovator Accelerator Program. The track is designed to identify and support companies with novel medical or digital health technologies aligned with the lifesaving mission of the American Heart Association.

These eight finalists have specific solutions and applications identified by experts for their potential to positively impact women’s cardiovascular and brain health outcomes:

  • Kelvin Health, a health care technology company that uses mobile thermal imaging and artificial intelligence (AI) to provide quick, non-invasive diagnostics for vascular diseases.
  • LightHearted AI Health, a health technology company that offers a contactless biometric device using laser light and AI to quickly and accurately detect heart conditions, aiming to make heart diagnostics more accessible and affordable.
  • MOMM Diagnostics, a health-tech startup developing a rapid, highly sensitive blood test designed to detect preeclampsia early in pregnancy using a simple fingerstick sample and a compact reader, enabling faster, more accurate diagnoses during routine checkups.
  • Powerful Medical, a health technology company that uses AI to help doctors quickly and accurately interpret electrocardiograms (ECGs), which are used to record the electrical activity of the heart.
  • Reach Neuro, a medical technology company that has developed an implantable device delivering small electrical pulses to the spinal cord, helping stroke survivors regain control of their arm and hand movements, even years after their stroke, by enhancing communication between the brain and muscles.
  • Sinaptica Therapeutics, a medical technology company developing a non-invasive, personalized brain stimulation therapy aimed at slowing the progression of Alzheimer's disease by enhancing memory-related brain networks.
  • SynchNeuro, a health technology company developing a non-invasive, behind-the-ear wearable device that uses brain signals to monitor blood sugar levels, aiming to help people with prediabetes manage their health without needles or implants.
  • Veravas, a health technology company that has developed a patented platform using magnetic beads to purify and concentrate biomarkers from complex samples like blood or saliva, enabling earlier and more accurate detection of diseases such as Alzheimer's.

The selected health tech companies now also become official members of the Medtech Innovator program for this year, which includes access to networking opportunities, funding and increased visibility within the medical technology industry. In addition, they will receive specialized mentorship, coaching and capacity building from American Heart Association Ventures, customized to their focus on cardiovascular and/or brain conditions and diseases.

As participants in the Heart and Brain Health Accelerator, these companies qualify to participate in the MedTech Innovator Competition Finals, held at the MedTech Conference on Oct. 5-8, 2025, in San Diego. Astellas Rx+ sponsors the American Heart Association Heart and Brain Heath Accelerator track.

The companies were selected by expert volunteers on an American Heart Association advisory committee.


Related Content

News | AHA

July 16, 2025 — The American Heart Association has appointed two leading health and science leaders, Jennifer Ashton, M ...

Home July 16, 2025
Home
News | AHA

May 8, 2025 — Nancy Brown, chief executive officer of the American Heart Association, has been named to TIME’s 2025 ...

Home May 12, 2025
Home
News | AHA

July 24, 2024 — Increasing ketone supply to the heart in mice with heart failure with preserved ejection fraction (HFpEF ...

Home July 24, 2024
Home
News | AHA

July 9, 2024 — The American Heart Association, celebrating 100 years of lifesaving service as the world’s leading ...

Home July 09, 2024
Home
News | AHA

July 24, 2024 — During the American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024, BCVS ...

Home July 05, 2024
Home
News | AHA

June 18, 2024 — At least 6 in 10 adults in an older, more diverse U.S. population could be affected by cardiovascular ...

Home June 18, 2024
Home
News | AHA

May 24, 2024 — The American Heart Association has issued a statement warning that false information about COVID ...

Home May 24, 2024
Home
News | AHA

February 9, 2024 — Injection of a substance to block an artery feeding the dura (protective sack around the brain) — ...

Home February 09, 2024
Home
News | AHA

February 8, 2024 — The American Heart Association (AHA), currently celebrating its centennial year, announced that it is ...

Home February 08, 2024
Home
News | AHA

February 8, 2024 — The latest late-breaking science from the second day of the American Stroke Association’s ...

Home February 08, 2024
Home
Subscribe Now